These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 872448)

  • 1. A study of complement fixation by rheumatoid factor using a haemolytic assay system.
    Taylor-Upsahl MM; Johnson PM; Mellbye OJ; Natvig JB
    Clin Exp Immunol; 1977 May; 28(2):204-11. PubMed ID: 872448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement fixation by rheumatoid factor.
    Tanimoto K; Cooper NR; Johnson JS; Vaughan JH
    J Clin Invest; 1975 Mar; 55(3):437-45. PubMed ID: 1078825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue.
    Taylor-Upsahl MM; Abrahamsen TG; Natvig JB
    Clin Exp Immunol; 1977 May; 28(2):197-203. PubMed ID: 326444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rheumatoid factor on complement-mediated phagocytosis.
    McDuffie FC; Brumfield HW
    J Clin Invest; 1972 Dec; 51(12):3007-14. PubMed ID: 4640945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor.
    Luthra HS; McDuffie FC; Hunder GG; Samayoa EA
    J Clin Invest; 1975 Aug; 56(2):458-66. PubMed ID: 125289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activating properties of complexes containing rheumatoid factor in synovial fluids and sera from patients with rheumatoid arthritis.
    Elson CJ; Carter SD; Cottrell BJ; Scott DG; Bacon PA; Wallington TB
    Clin Exp Immunol; 1985 Feb; 59(2):285-92. PubMed ID: 3978872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixation by a two-component antibody system: immunoglobulin G and immunoglobulin M anti-globulin (rheumatoid factor). Parodoxical effect related to immunoglobulin G concentration.
    Schmid FR; Roitt IM; Rocha MJ
    J Exp Med; 1970 Oct; 132(4):673-93. PubMed ID: 5508376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor.
    Gabriel A; Agnello V
    J Clin Invest; 1977 May; 59(5):990-1001. PubMed ID: 323292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of IgG, IgM rheumatoid factor, and their complexes in the induction of polymorphonuclear leukocyte chemotactic factor from complement.
    Wagner T; Abraham G; Baum J
    J Clin Invest; 1974 Jun; 53(6):1503-11. PubMed ID: 4133792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis.
    Robbins DL; Wistar R
    J Rheumatol; 1985 Jun; 12(3):437-43. PubMed ID: 3900391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor.
    Davidson A; Lopez J; Sun D; Prus D
    J Immunol; 1992 Jun; 148(12):3873-8. PubMed ID: 1376343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The subclass distribution of human IgG rheumatoid factor.
    Cohen PL; Cheek RL; Hadler JA; Yount WJ; Eisenberg RA
    J Immunol; 1987 Sep; 139(5):1466-71. PubMed ID: 3624864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement-fixing material in ther sera of patients with rheumatoid arthritis.
    McDuffie FC; Hunder GG; Clark RJ
    Clin Exp Immunol; 1978 May; 32(2):218-25. PubMed ID: 668197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the complement activation capacity of soluble IgG aggregates and immune complexes by IgM-rheumatoid factor.
    Doekes G; Schouten J; Cats A; Daha MR
    Immunology; 1985 Jul; 55(3):555-64. PubMed ID: 4018839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgG and IgM rheumatoid factors and complement activation in extraarticular rheumatoid disease.
    Jakle C; Feigal DW; Robbins DL; Shapiro R; Wiesner K
    J Rheumatol; 1985 Apr; 12(2):227-32. PubMed ID: 3875718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG rheumatoid factor: analysis of various species of IgG for detection by radioimmunoassay.
    Pope RM; McDuffy SJ
    J Lab Clin Med; 1981 Jun; 97(6):842-53. PubMed ID: 7229514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid factor-producing cells detected by direct hemolytic plaque assay.
    Vaughan JH; Chihara T; Moore TL; Robbins DL; Tanimoto K; Johnson JS; McMillan R
    J Clin Invest; 1976 Oct; 58(4):933-41. PubMed ID: 787010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.